Key Metrics
CiteScore 

16.7
Impact Factor 

10 - 15
Scite Index 

0.93 5-Year SI

SJR 

Q1Medicine (miscellaneous)

SNIP 

1.75
Recommended pre-submission checks
Powered by 

Topics Covered on Theranostics
Theranostics Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | IVYSPRING INT PUBL |
| Language | English |
| Frequency | Irregular |
| Article Processing Charges | AUD 2500 |
| Publication Time | 12 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Frequency | Irregular |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in Theranostics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Theranostics
Multifunctional nanozyme platforms in central nervous system therapies: from rational design to translational medicine
- 29 Jul 2026
- Theranostics
MiR-15a-5p outperforms anti-VEGF drug in ocular neovascularization by providing dual anti-angiogenic and neuroprotective effects
- 29 Jul 2026
- Theranostics
A mechanobiology-driven cell-derived ECM bioink for engineering 3D glioblastoma tumor microenvironment models
- 29 Jul 2026
- Theranostics
Magnetofection-mediated siRNA delivery ameliorates cartilage damage in Kashin-Beck disease via targeting SIRT3 and protecting primary cilia
- 22 Jul 2026
- Theranostics
Clinically accessible drug-based nano-assemblies with self-targeting ability for NIR-II fluorescence imaging-guided surgery in triple-negative breast cancer
- 22 Jul 2026
- Theranostics
CCR2 deficiency protects against doxorubicin-induced cardiac dysfunction through enhanced IL12B-dependent autophagy
- 22 Jul 2026
- Theranostics
Multifunctional nanozyme platforms in central nervous system therapies: from rational design to translational medicine
- 29 Jul 2026
- Theranostics
MiR-15a-5p outperforms anti-VEGF drug in ocular neovascularization by providing dual anti-angiogenic and neuroprotective effects
- 29 Jul 2026
- Theranostics
A mechanobiology-driven cell-derived ECM bioink for engineering 3D glioblastoma tumor microenvironment models
- 29 Jul 2026
- Theranostics
Magnetofection-mediated siRNA delivery ameliorates cartilage damage in Kashin-Beck disease via targeting SIRT3 and protecting primary cilia
- 22 Jul 2026
- Theranostics
Clinically accessible drug-based nano-assemblies with self-targeting ability for NIR-II fluorescence imaging-guided surgery in triple-negative breast cancer
- 22 Jul 2026
- Theranostics
CCR2 deficiency protects against doxorubicin-induced cardiac dysfunction through enhanced IL12B-dependent autophagy
- 22 Jul 2026
- Theranostics
FAQs on Theranostics
How long has Theranostics been actively publishing? 
What is the publishing frequency of Theranostics? 
How many articles did Theranostics publish last year? 
What is the eISSN & pISSN for Theranostics? 
What is Citescore for Theranostics? 
What is SNIP score for Theranostics? 
What is the SJR for Theranostics? 
Who is the publisher of Theranostics? 
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary